Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01501487
Title MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I
Recruitment Completed
Gender female
Phase FDA approved
Variant Requirements No
Sponsors Agendia
Indications

breast cancer

Therapies

Cyclophosphamide + Docetaxel + Doxorubicin

Cyclophosphamide + Epirubicin + Fluorouracil

Paclitaxel

Pegfilgrastim

Cyclophosphamide + Docetaxel

Cyclophosphamide + Doxorubicin

Carboplatin + Docetaxel + Trastuzumab

Docetaxel + Pertuzumab + Trastuzumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of South Alabama, Mitchell Cancer Institute Mobile Alabama 36688 United States Details
Morton Plant Mease Health Care Clearwater Florida 33756 United States Details
University of Miami Miami Florida 33124 United States Details
University of South Florida Breast Cancer Program Tampa Florida 33613 United States Details
Helen Ellis Memorial Hospital Tarpon Springs Florida 34689 United States Details
Eastchester Center for Cancer Care Bronx New York 10469 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43212 United States Details
University of Oklahoma, Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
Texas Health, Plano Cancer Institute Plano Texas 75093 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field